|
[1]
|
Yedjou, C., Izevbigie, E. and Tchounwou, P. (2008) Preclinical Assessment of Vernonia Amygdalina Leaf Extracts as DNA Damaging Anti-Cancer Agent in the Management of Breast Cancer. International Journal of Environmental Re-search and Public Health, 5, 337-341. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Chen, W., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132.
[Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
DeSantis, C.E., et al. (2014) Cancer Treatment and Survivorship Statistics, 2014. CA: A Cancer Journal for Clinicians, 64, 252-271. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Louvet, C., et al. (2005) Identification of a New Member of the CD20/FcepsilonRIbeta Family Overexpressed in Tolerated Allografts. American Journal of Transplantation, 5, 2143-2153.
[Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Segovia, M., et al. (2014) Autologous Dendritic Cells Prolong Allograft Survival through Tmem176b-Dependent Antigen Cross-Presentation. American Journal of Trans-plantation, 14, 1021-1031. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Eon Kuek, L., et al. (2016) The MS4A Family: Counting Past 1, 2 and 3. Immunology & Cell Biology, 94, 11-23.
|
|
[7]
|
Condamine, T., et al. (2010) Tmem176B and Tmem176A Are Associated with the Immature State of Dendriticcells. Journal of Leukocyte Biology, 88, 507-515. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Cuajungco, M.P., et al. (2012) Abnormal Accumulation of Human Transmembrane (TMEM)-176A and 176B Proteins Is Associated with Cancer Pathology. Acta Histochemica, 114, 705-712.
[Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Segovia, M., et al. (2019) Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Acti-vation. Cancer Cell, 35, 767-781.e6.
|
|
[10]
|
DeSantis, C., et al. (2014) Breast Cancer Statistics, 2013. CA: A Cancer Journal for Clinicians, 64, 52-62.
[Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Lurton, J., et al. (1999) Isolation of a Gene Product Expressed by a Subpopulation of Human Lung Fibroblasts by Differential Display. American Journal of Respiratory Cell and Molecular Biology, 20, 327-331.
[Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Gottschling, S., et al. (2012) Establishment and Comparative Characterization of Novel Squamous Cell Non-Small Cell Lung Cancer Cell Lines and Their Corresponding Tumor Tissue. Lung Cancer, 75, 45-57.
[Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Cao, Q., et al. (2016) MicroRNA-7 Inhibits Cell Proliferation, Migration and Invasion in Human Non-Small Cell Lung Cancer Cells by Targeting FAK through ERK/MAPK Signaling Pathway. Oncotarget, 7, 77468-77481.
[Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Lee, C.H., Liang, C.W. and Espinosa, I. (2010) The Utility of Discovered on Gastrointestinal Stromal Tumor 1 (DOG1) Antibody in Surgical Pathology—The GIST of It. Advances in Anatomic Pathology, 17, 222-232.
[Google Scholar] [CrossRef]
|
|
[15]
|
Su, Z., et al. (2015) Apoptosis, Autophagy, Necroptosis, and Cancer Metastasis. Molecular Cancer, 14, 48.
|
|
[16]
|
Adams, J.M. and Cory, S. (2007) The Bcl-2 Apoptotic Switch in Cancer Development and Therapy. Oncogene, 26, 1324-1337. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Hasson, S.P., et al. (2013) Endocrine Resistance in Breast Cancer: Focus on the Phosphatidylinositol 3-Kinase/Akt/ Mammalian Target of Rapamycin Signaling Pathway. Breast Care (Basel), 8, 248-255.
[Google Scholar] [CrossRef] [PubMed]
|